- Retrospective and prospective cohort of 683 critically ill adults with confirmed or probable 2009 influenza A across 35 U.S. adult ICUs over one year.
- Exposure was bacterial coinfection (bacteremia or presumed bacterial pneumonia) documented within 72 hours of ICU admission, present in 207 patients (30.3%).
- Hospital mortality was 31% with coinfection versus 21% without (p=.002), and shock at admission was more common (21% vs. 10%; p=.0001).
- Staphylococcus aureus at admission (RR 2.82; 95% CI 1.76-4.51) and immunosuppression (RR 1.57; 95% CI 1.20-2.06) were independently associated with mortality.
Critical care
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Secondary analysis of a prospective cohort of 2,743 critically ill ICU patients with ARDS risk factors at a tertiary academic center.
- Exposure was statin receipt within 24 hours of ICU admission, given to 413 patients (15%).
- Statin users had lower unadjusted ARDS odds (OR 0.56, 95% CI 0.43-0.73), but after propensity matching this was not significant (OR 0.79, 95% CI 0.57-1.10).
- Statins were not associated with ARDS mortality, organ dysfunction, or ventilator-free days.
- This prospective cohort of 1029 adult EMS-treated out-of-hospital cardiac arrest patients across seven US and Canadian regions used electronically recorded compression depth data.
- Compression depth was an exposure rather than an intervention, and adjusted odds ratios for ROSC, 1-day survival, and discharge were compared across depth measures.
- Median depth was 37.3 mm, with 52.8% of cases below 38 mm and 91.6% below 50 mm, and depth was inversely associated with compression rate (p < .001).
- Greater depth showed strong trends toward better survival outcomes, but the authors found no clear evidence to support or refute the 2010 target of over 50 mm.
- Secondary analysis of 2,022 patients from Acute Respiratory Distress Syndrome Network trials, with 1,800 used to build a classification tree and 222 held out for validation.
- The tree used 54 pre-randomization variables, with selected predictors including age over 63, blood urea nitrogen over 15 mg/dL, shock, respiratory rate over 21, and minute ventilation over 13.9 L/min.
- Its expected prediction error (28% vs. 26%, p = .18) and validation AUC (0.71 vs. 0.73, p = .71) were similar to an APACHE III-based model.
- The authors conclude the simpler tree performed comparably to APACHE III and flagged minute ventilation as a possible novel predictor of death.
- Secondary analysis of a prospective multicenter international observational cohort of 3,855 consecutive nonsurgical adults at risk for acute lung injury, across 22 hospitals.
- Patients taking aspirin before admission (976, 25.3%) were compared with those who were not, with aspirin propensity used in the analysis; no intervention was given.
- Unadjusted analysis showed lower acute lung injury odds with aspirin (OR 0.65; 95% CI 0.46-0.90; p = .010), but stratifying by propensity deciles attenuated this (pooled OR 0.70; 95% CI 0.48-1.03; p = .072).
- The authors found no statistically significant association after adjusting for propensity to receive aspirin and suggested that a prospective clinical trial is warranted.
- Prospective observational study of 418 Ugandan adults with sepsis and organ dysfunction at three referral hospitals.
- Admission point-of-care glucose was classified as hypo-, eu-, or hyperglycemic and compared with in-hospital mortality.
- Hypoglycemia was associated with higher mortality than euglycemia (35.3% vs 19.3%), with adjusted HR 1.9 (95% CI 1.1-3.3, p=.03).
- Altered mental status was a poor marker for hypoglycemia, with 25% sensitivity and 86% specificity, so clinical examination was judged unreliable.
- A laboratory study in male Balb/c mice at a university lab examined how acute alcohol affects granulocyte production during E. coli septicemia.
- Mice received intraperitoneal ethanol (5 g/kg) or saline 30 minutes before an intravenous E. coli challenge.
- E. coli infection increased stem cell antigen-1 expression and expansion of granulocyte progenitors, and alcohol suppressed these increases and impaired recovery of mature granulocytes.
- Stem cell antigen-1 knockout mice failed to expand immature progenitors and made fewer new circulating granulocytes after challenge, which the authors propose as a mechanism of impaired host defense.
- Secondary analysis of plasma biomarkers and clinical data from two NIH ARDS Network ventilator trials, a derivation cohort (n = 547) and a replication cohort (n = 500), in university ICUs.
- Adding five plasma biomarkers (ICAM-1, von Willebrand factor, IL-8, sTNF-R1, SP-D) to APACHE III score at enrollment was compared with clinical predictors alone for mortality risk prediction.
- Net reclassification improvement was 22% (95% CI 13% to 32%; p < .001) in the derivation cohort and 17% (95% CI 7% to 26%; p < .001) in the replication cohort.
- A reduced three-biomarker panel (IL-8, sTNF-R1, SP-D) performed nearly as well in both cohorts, and the authors suggest combining three or more biomarkers may help select high-risk patients for trials.
- Historical cohort of 9,518 adult ICU patients across 35 California hospitals from 2001 to 2004, comparing white, Black, Hispanic, and Asian/Pacific Islander patients.
- Risk-adjusted mortality and ICU length of stay were compared across racial and ethnic groups after adjusting for demographic, clinical, and socioeconomic factors and DNR status.
- Crude mortality was 15.9% overall, highest in Asian patients (18.6%) and lowest in Black patients (15.0%), but group differences were not significant after full adjustment.
- Black patients had more physiologic derangements at ICU admission and were less likely to have DNR orders, while the authors attribute any remaining disparities to hospital quality differences.
- A prospective randomized experimental study tested polynitroxylated pegylated hemoglobin in rat neuron cultures and in a mouse model of brain injury with hemorrhagic hypotension.
- After controlled cortical impact and hemorrhage, mice were resuscitated with PNPH, lactated Ringer's, or Hextend, and shed blood was reinfused.
- PNPH and Hextend each required less resuscitation volume than lactated Ringer's (both p<.05), and only PNPH improved mean arterial pressure versus lactated Ringer's (p<.05).
- PNPH-treated mice had fewer Fluoro-Jade C positive neurons in CA1 than Hextend or lactated Ringer's, and fewer in CA3 than Hextend (p<.05).
- Observational cohort of 60 critically ill patients at a single tertiary academic center in Tennessee, with smoking history taken from patients, surrogates, or the chart.
- Multiple biomarkers of tobacco exposure (serum and urine cotinine, urine NNAL, hair and nail nicotine) were compared with smoking history.
- Serum cotinine plus urine NNAL identified 6 of 28 history-defined nonsmokers (21%) as active smokers and 21 (75%) as secondhand smoke exposed.
- The biomarkers correlated strongly with each other (r = .69-.95, p < .0001), and the authors suggest they will help future studies of smoking and critical illness.
- Secondary analysis of a single-center randomized pilot trial (EDEN) including 175 medical ICU patients with acute respiratory failure.
- Exposure was plasma adiponectin measured within 48 hours of respiratory failure, with no intervention applied.
- Higher early adiponectin was associated with 28-day mortality (OR 1.59 per 5 μg/mL; 95% CI 1.15-2.21; p=.006).
- Adiponectin rose by day 6 only in survivors, and the authors suggest adipose-derived factors may modulate the critical illness response.
- This is a narrative primer that reviews selected critical care clinical trials, with no pooled sample or new patient data reported.
- It covers trial design features such as patient selection, bias, sample size calculation, choice of controls, and primary outcome measure.
- No effect sizes, confidence intervals, or p values are reported; the review focuses on how design features shape the interpretation of results.
- The authors conclude that checking whether arms were comparable and whether the primary outcome matters clinically can guide decisions about applying findings.
- Prospective observational cohort of 56 mechanically ventilated patients with acute lung injury, recruited from two intensive care units in university-affiliated hospitals.
- Baseline plasma angiopoietin-2 relative to angiopoietin-1 was measured by ELISA within 48 hours of acute lung injury diagnosis, alongside pulmonary dead-space fraction; no treatment was assigned.
- The ratio was higher in patients who died (median 58 vs. 14; p = .01), and in a multivariable model stratified by dead-space fraction it predicted death with adjusted OR 4.3 (95% CI 1.3-13.5) in those with elevated dead-space fraction.
- The authors suggest the ratio may be a prognostic marker of endothelial activation that, with dead-space fraction, could help risk stratify patients and select subgroups for future trials; correlations with other endothelial markers were only moderate to weak.
- Systematic review of adult acute respiratory failure studies: three randomized trials and three cohort studies, none specifically enrolling patients with influenza.
- Extracorporeal membrane oxygenation was compared with non-extracorporeal membrane oxygenation care; pooled randomized trial mortality risk ratio was 0.93 (95% CI 0.71 to 1.22), with significant heterogeneity.
- The most recent trial reported reduced mortality and severe disability at 6 months when extracorporeal membrane oxygenation was considered, and observational data linked it to better mortality in viral pneumonia.
- The authors found insufficient evidence to recommend extracorporeal membrane oxygenation for influenza-related respiratory failure and advised considering it as one salvage therapy.
- This is a perspective piece on critical care research during the 2009-2010 H1N1 influenza pandemic, with no sample size or patient population reported.
- It describes the early international response, including observational case report forms, registry and trial design, and collaboration among critical care research organizations.
- The abstract gives no quantitative results, though it says the early results of these collaborations are described.
- The authors argue that pre-planned, quickly modifiable study designs, pre-reviewed ethics and funding, and national and international cooperation are needed for future pandemics or disasters.
- Controlled animal study using 177 male Sprague-Dawley rats in an endovascular perforation model of subarachnoid hemorrhage, with sham-operated controls.
- Rats received intracerebroventricular recombinant osteopontin at two doses (0.02 and 0.1 microg), compared with albumin or vehicle given before the hemorrhage.
- Recombinant osteopontin prevented losses in body weight, neurologic impairment, brain edema and blood-brain barrier disruption; no effect sizes or p values are reported in the abstract.
- Authors link the benefit to suppressed NF-kB activity and MMP-9 induction, with preserved tissue inhibitor of MMP-1, laminin and zona occludens-1, and conclude it is effective for early brain injury.
- Phase I, dose-escalation multicenter prospective study of 60 patients with supratentorial intracerebral hemorrhage and systolic pressure of at least 170 mm Hg, presenting within 6 hours.
- Intravenous nicardipine targeted three systolic ranges (170-200, 140-170, and 110-140 mm Hg) across successive cohorts of 18, 20, and 22 patients.
- Nine of 60 patients had treatment failures, all in the most aggressive tier, and neurologic deterioration rose from 6% to 10% to 18% across tiers, below prespecified stopping thresholds.
- The authors concluded that safety was acceptable and that the results support a larger randomized trial; 3-month mortality was 17%, 10%, and 23% by tier, described as lower than expected.
- Randomized laboratory study in male Sprague Dawley rats (270 to 330 g) at a university research lab, comparing resuscitation with mesenteric venous hypertension using normal saline versus hypertonic saline.
- Intervention was 80 mL/kg hypertonic saline added to normal saline resuscitation, compared against normal saline alone, with edema, fluid volumes, hydraulic conductivity, and aquaporin measurements after 6 hours.
- Hypertonic saline decreased intestinal edema and increased urine, intraluminal, and peritoneal fluid volume, with increased hydraulic conductivity at mucosal and seromuscular surfaces; no effect sizes or p values are reported in the abstract.
- The authors conclude that hypertonic saline reduces edema through increased membrane conductivity, linked to aquaporin 4 up-regulation, and suggest aquaporin 4 as a possible therapeutic target.
- Retrospective analysis of 513 patients with acute lung injury from the NIH ARDS Network Fluid and Catheter Treatment Trial, all randomized to a pulmonary artery catheter.
- Exposures were baseline exam signs, CVP, 24-hour fluid output, and central venous oxygen saturation, compared against PAC cardiac index and mixed venous saturation.
- Low cardiac index occurred in 8.1% and mixed venous saturation below 60% in 15.5%; the combined exam findings had sensitivity of 12% and 8%, but negative predictive values of 93% and 86%.
- Central venous saturation below 70% had sensitivity 84%, specificity 70%, PPV 31%, and NPV 96% for mixed venous saturation below 60%; the authors concluded exam findings were not useful, while saturation of 70% or higher may help exclude low mixed venous saturation.
- Secondary analysis of two ARDSnet trials, with 414 patients used to develop the model and 459 used to validate it, all with acute lung injury.
- A four-variable point score (hematocrit, bilirubin, fluid balance, and age) was built from baseline data, with no intervention given.
- Predicted mortality rose from 8% at 0 points to 70% at 4+ points, and observed validation mortality closely tracked these estimates.
- In the validation cohort, the score's AUC was lower than APACHE III (0.68 vs. 0.75, p = 0.03), and the authors call for validation in nonclinical-trial populations.
- Retrospective cohort of 2,451 mechanically ventilated adults with ALI enrolled in ARDS Network randomized trials between 1996 and 2005.
- The exposure was enrollment period, with adjustment for covariates including use of lower tidal volume ventilation and illness severity.
- Crude mortality fell from 35% in 1996-1997 to 26% in 2004-2005 (test for trend p < 0.0005), and the trend persisted after adjustment (p = 0.002).
- No statistically significant temporal trends were found within individual causes of lung injury, including pneumonia, sepsis, aspiration, and trauma.
- Randomized controlled animal study in adult male C57BL/6 mice, comparing control diet, zinc-deficient diet, and zinc repletion before cecal ligation and puncture.
- Zinc-deficient mice were compared with control-diet mice under polymicrobial sepsis induced by CLP, with sham-operated mice as additional controls.
- Sepsis mortality was 90% with zinc deficiency versus 30% on control diet, and deficient CLP mice had higher cytokines and more organ injury, especially lungs and spleen.
- Zinc supplementation normalized inflammation and reduced tissue damage and mortality, but the authors describe the protection as incomplete.
- Retrospective analysis of prospectively collected plasma from 645 patients in a multicenter ARDS Network lower-tidal-volume trial across ten university ICUs.
- Baseline G-CSF was examined as a continuous log10 measure and in quartiles, adjusting for ventilation strategy and other covariates.
- Each log10 rise in baseline G-CSF tracked with higher odds of death (OR 1.2, 95% CI 1.01 to 1.4); the highest quartile also linked to fewer ventilator-free days.
- G-CSF fell over time in both tidal volume groups with no significant difference between them, and the authors describe a U-shaped mortality pattern in sepsis-related ALI.
- Prospective animal study in ICR/HSD mice comparing Candida albicans intravenous infection with cecal ligation and puncture (polymicrobial sepsis) at a university research laboratory.
- Leukocyte Dectin-1 expression was measured by flow cytometry in blood, spleen, and peritoneal exudate, with isolated neutrophils also treated ex vivo with glucans, mannan, LPS, or cytokines.
- In Candida infection, Dectin-1-positive blood and splenic leukocytes rose from 23.5% to 58.9%, mainly from neutrophilia, while per-cell Dectin-1 on neutrophils fell by 49.0% to 53.3%.
- Polymicrobial sepsis reduced blood Dectin-1-expressing cells by up to 51.4% but raised peritoneal Dectin-1-expressing cells by 774%; only glucans reduced Dectin-1-positive neutrophils ex vivo, supporting differential regulation.
- Cross-sectional survey of 1384 ICU professionals (970 physicians, 322 nurses) from 41 North American hospitals, meetings, and an ATS email list, conducted October 2006 to May 2007.
- Compared with a 2001 survey in which only 16% used a validated delirium screening tool, this survey asked about delirium beliefs, screening, and sedation practices.
- Among 774 respondents who screen for delirium, 258 (33%) used a specific tool, and 396 of 1355 (29%) reported no sedation protocol.
- Although 76% (990 of 1309) had a written spontaneous awakening trial policy, only 44% (446 of 1019) performed trials on more than half of ICU days.
- Laboratory study in 36 male Sprague-Dawley rats using a cardiac arrest model, with hypothermia maintained for 3 hours and animals killed at 5 or 24 hours.
- Post-arrest hypothermia was compared with arrest alone for effects on liver CYP3A2 and CYP2E1 activity and mRNA, and on plasma IL-6.
- At 24 hours, CYP3A2 and CYP2E1 activity fell to 55.7% ± 12.8% and 46.8% ± 29.7% of control (p < 0.01).
- Hypothermia attenuated the arrest-related drop in enzyme activity and the IL-6 rise, and IL-6 reduced PXR-mediated CYP3A2 promoter transcription in HepG2 cells.
- Post hoc analysis of a prospective observational cohort of 125 mechanically ventilated adults in one tertiary medical ICU.
- Burst suppression on bispectral index EEG was the exposure, compared with patients who did not show it.
- Burst suppression occurred in 39% and was linked to higher 6-month mortality (59% vs 33%), HR 2.04 (95% CI 1.12-3.70, p=0.02) after time-dependent Cox adjustment.
- The authors describe burst suppression as an independent predictor of 6-month death and call for larger prospective studies.
- Laboratory study using isolated blood cells from healthy volunteers, performed in a university research lab rather than with patients.
- Cells were exposed to 20 mM hypertonic saline, lipopolysaccharide, or both, with gammadeltaT cells cocultured with autologous neutrophils.
- Neutrophil killing within 120 minutes rose from 15.6 ± 3.4% to 23.7 ± 2.1% with lipopolysaccharide and to 31.8 ± 3.1% when hypertonic saline was added.
- The authors conclude that hypertonic saline boosts gammadeltaT cell clearance of inflammatory neutrophils, possibly by increasing neutrophil surface HSP72, and may aid lung protection.
- A single-center pediatric ICU study with an observational cohort of 37 children with multiorgan dysfunction, followed by a small randomized trial.
- In the trial, children with severe TAMOF were randomized to intensive plasma exchange or standard therapy.
- Children with TAMOF had lower ADAMTS-13 activity than children with MOF without thrombocytopenia (p<0.05), and all non-survivors had VWF-rich microvascular thromboses at autopsy.
- Plasma exchange restored ADAMTS-13 activity and organ function versus standard therapy in the randomized patients, reported only as p<0.05.
- This is a narrative review built from a PubMed search, not a primary study, and it covers influenza diagnosis, complications, therapy, and infection control.
- The review is framed around intensivist concerns, and the abstract notes a setting of a 450-bed teaching hospital ICU.
- The authors report that seasonal influenza causes over 200,000 US hospitalizations and 41,000 deaths yearly, ranking as the seventh leading cause of death.
- They conclude that many health care workers have limited influenza knowledge, clinical data to guide therapy are sparse, and intensivists should recognize seasonal influenza's severe morbidity.
- Retrospective analysis of prospectively collected plasma from 779 patients in a multicenter ventilation trial, with 99 cardiogenic pulmonary edema patients and ten controls.
- Baseline plasma protein C and plasminogen activator inhibitor-1 levels were compared across ARDS/ALI patients, cardiogenic edema patients, and healthy controls.
- Lower protein C and higher PAI-1 were strong independent predictors of mortality and of ventilator-free and organ-failure-free days, with a synergistic interaction for death.
- The authors suggest these markers may help identify patients at highest risk of poor outcomes and could inform development of new therapies.
- A Markov cost-effectiveness model from a healthcare payor perspective, using a base-case critically ill 65-year-old patient.
- Compared prolonged mechanical ventilation (at least 21 days) with comfort care leading to withdrawal of ventilation.
- Base-case cost was $55,460 per life-year gained and $82,411 per quality-adjusted life-year gained versus withdrawal.
- Cost per QALY exceeded $100,000 when age was 68 or older or predicted 1-year mortality exceeded 50%.
- Prospective observational study of 70 patients with acute respiratory failure in medical and surgical ICUs at one center, using esophageal balloon catheters.
- Airway, esophageal, and gastric pressures were recorded at end-expiration, end-inflation, and during an end-inspiratory hold to estimate transpulmonary pressure.
- Esophageal pressure averaged 17.5 cm H2O at end-expiration and 21.2 cm H2O at end-inflation; estimated transpulmonary pressure at end-inflation was 21.4 cm H2O.
- Airway pressure explained only 24% of transpulmonary pressure variance (R = .243), while esophageal pressure accounted for 52%, so the authors argue chest wall mechanics limit airway-based estimates.
- Retrospective cohort of 1,488 mechanically ventilated adults with acute lung injury from Project IMPACT, across 106 ICUs in 84 hospitals (1995-2001).
- Exposure was body mass index, analyzed as a continuous variable and in categories; no intervention was assigned.
- After risk adjustment, BMI was independently associated with hospital mortality; underweight patients had higher odds (aOR 1.94, 95% CI 1.05-3.60) than normal-weight patients.
- Overweight and obese categories had lower adjusted odds of death, and heparin prophylaxis partly mediated the protective effect of severe obesity.